Scholarlink

<p>The main treatment strategy for bacterial vaginosis (BV) is antibiotic therapy, but they are not effective in restoring the vaginal microecology, which can lead to recurrence. This study aimed to isolate the dominant lactobacilli strains from the vagina of healthy Chinese women, evaluate their potential probiotic properties and explore their alleviative effect on BV infected mice. Our study isolated 43 strains of vaginal-dominant <i>Lactobacillus</i>. Four strains of <i>Lactobacillus. crispatus</i>, four strains of <i>Lactobacillus. gasseri</i>, and two strains of <i>Lactobacillus. jensenii</i> showed strong inhibitory effects on <i>Gardnerella vaginalis</i> and were safe in vitro. Subsequently, through principal component analysis on seven functional indicators of these 10 strains, <i>Lact. crispatus</i> G-7, <i>Lact. gasseri</i> B-5, and <i>Lact. jensenii</i> M-1 ranked the top beneficial strains and were finally selected as the candidate therapeutic strain for in vivo experiments. Animal experiments showed that <i>Lact. crispatus</i> G-7 was superior to other <i>Lactobacillus</i> species and the positive control metronidazole in restoring vaginal health (pH and H<sub>2</sub>O<sub>2</sub>). Additionally, it also significantly reduced the expression of pro-inflammatory cytokines IL-1β, IL-6, and TNF-α while increasing the expression of anti-inflammatory cytokine IL-10. H&amp;E staining and 16S rRNA gene sequencing showed that <i>Lact. crispatus</i> G-7 can alleviate the inflammatory damage caused by <i>G. vaginalis</i> and restored vaginal microecology. Among the isolated dominant <i>Lactobacillus</i> strains from the vagina, <i>Lact. crispatus</i> G-7 has been identified as the most effective in the treatment of <i>G. vaginalis</i> imparted BV. This strain is therefore a candidate for developing promising treatments for BV.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Alleviative Effect of Vaginal Lactobacilli with Probiotic Potential from Healthy Chinese Women on Bacterial Vaginosis Caused by Gardnerella vaginalis in Mice

  • 期刊论文

  • 发表日期：

    2025年7月24日

查看全文
  • Congcong Li,
  • Yimin Cheng,
  • Tingting Zong,
  • Shuqi Guo,
  • Hongli Zhu,
  • Penggao Dai,
  • Chao Chen,
  • Huijuan Wang

摘要

The main treatment strategy for bacterial vaginosis (BV) is antibiotic therapy, but they are not effective in restoring the vaginal microecology, which can lead to recurrence. This study aimed to isolate the dominant lactobacilli strains from the vagina of healthy Chinese women, evaluate their potential probiotic properties and explore their alleviative effect on BV infected mice. Our study isolated 43 strains of vaginal-dominant Lactobacillus. Four strains of Lactobacillus. crispatus, four strains of Lactobacillus. gasseri, and two strains of Lactobacillus. jensenii showed strong inhibitory effects on Gardnerella vaginalis and were safe in vitro. Subsequently, through principal component analysis on seven functional indicators of these 10 strains, Lact. crispatus G-7, Lact. gasseri B-5, and Lact. jensenii M-1 ranked the top beneficial strains and were finally selected as the candidate therapeutic strain for in vivo experiments. Animal experiments showed that Lact. crispatus G-7 was superior to other Lactobacillus species and the positive control metronidazole in restoring vaginal health (pH and H2O2). Additionally, it also significantly reduced the expression of pro-inflammatory cytokines IL-1β, IL-6, and TNF-α while increasing the expression of anti-inflammatory cytokine IL-10. H&E staining and 16S rRNA gene sequencing showed that Lact. crispatus G-7 can alleviate the inflammatory damage caused by G. vaginalis and restored vaginal microecology. Among the isolated dominant Lactobacillus strains from the vagina, Lact. crispatus G-7 has been identified as the most effective in the treatment of G. vaginalis imparted BV. This strain is therefore a candidate for developing promising treatments for BV.